Zobrazeno 1 - 10
of 24
pro vyhledávání: '"C. Rinciog"'
Publikováno v:
Value in Health. 25:S341-S342
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e91d304f70dce7725a6f08ab6d4e0167
https://doi.org/10.1016/j.jval.2022.09.1690
https://doi.org/10.1016/j.jval.2022.09.1690
Publikováno v:
Value in Health. 25:S492
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76dd6642787f11236682e3f38e22ef06
https://doi.org/10.1016/j.jval.2022.09.2440
https://doi.org/10.1016/j.jval.2022.09.2440
Publikováno v:
Value in Health. 25:S124
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::797c545434fa47e905c1b2fb8f187698
https://doi.org/10.1016/j.jval.2022.09.600
https://doi.org/10.1016/j.jval.2022.09.600
Publikováno v:
Value in Health. 25:S344
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a6a112d90e326125ffa5dcdd62af742
https://doi.org/10.1016/j.jval.2022.09.1702
https://doi.org/10.1016/j.jval.2022.09.1702
Publikováno v:
Value in Health. 25:S9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47b936bc87ba8a69109aadc4210568f3
https://doi.org/10.1016/j.jval.2022.09.051
https://doi.org/10.1016/j.jval.2022.09.051
Autor:
A Pagotto, D Gonçalves-Bradley, V Kontogiannis, K Chalmers, B Langford, C Rinciog, L Sawyer, A Diamantopoulos
Publikováno v:
Value in Health. 25:S177-S178
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36c19d52c27a6a9e02a2eb53da652491
https://doi.org/10.1016/j.jval.2021.11.863
https://doi.org/10.1016/j.jval.2021.11.863
Autor:
S. Soulard, C. Rinciog, Caroline Dahlqvist, A. Gentilini, Antoine Froidure, A. Diamantopoulos, W. A. Wuyts, Benjamin Bondue
Publikováno v:
PharmacoEconomics-open, Vol. 4, no. 3, p. 449-458 (2020)
PharmacoEconomics-open, Vol. 4, no.1, p. 1-10 (2020)
PharmacoEconomics-open
PharmacoEconomics Open
PharmacoEconomics-open, Vol. 4, no.1, p. 1-10 (2020)
PharmacoEconomics-open
PharmacoEconomics Open
Nintedanib (Ofev®) and pirfenidone (Esbriet®) are recommended by international guidelines as treatment options for idiopathic pulmonary fibrosis (IPF).
info:eu-repo/semantics/published
info:eu-repo/semantics/published
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49addcfbc4d72987d76459a34705e041
https://hdl.handle.net/2078.1/226674
https://hdl.handle.net/2078.1/226674
Autor:
V Kontogiannis, A Pagotto, K Chalmers, D Gonçalves-Bradley, B Langford, C Rinciog, L Sawyer, A Diamantopoulos
Publikováno v:
Value in Health. 25:S189
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae786c92e25f3c72c7f4eb307bf9adb0
https://doi.org/10.1016/j.jval.2021.11.918
https://doi.org/10.1016/j.jval.2021.11.918
Autor:
A Pagotto, V Kontogiannis, D Gonçalves-Bradley, K Chalmers, B Langford, C Rinciog, L Sawyer, A Diamantopoulos
Publikováno v:
Value in Health. 25:S177
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d06a6a8795c853f50f30b1d0cbe7172
https://doi.org/10.1016/j.jval.2021.11.862
https://doi.org/10.1016/j.jval.2021.11.862
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.